Table 3.
WHO N° | Origin | Result for HIV antibodies | Reference Results Treponema pallidum | Reference Results HIV | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
INSTI Multiplex HIV-1/HIV-2/Syphilis antibody test | DPP HIV/Syphilis Assay | SD Bioline HIV/Syphilis Duo | Multiplo rapid TP/HIV Antibody test | |||||||||||||||||||||||||
Vitros Syphilis TPA assay | TP particle agglutination (TTPA) | Reference result for TP | Vironostika HIV Ag/Ab | Genscreen HIV 1/2 v2 | Innotest HIV Ag mAb | InnoLIA HIV1/2 Score | Reference result for HIV | |||||||||||||||||||||
Initial | Final | Initial | Final | Initial | Final | Initial | Final | S/CO | Result | Result | OD/CO | Result | OD/CO | Result | OD/CO | Result | gp120 | gp41 | p31 | p24 | p17 | gp105 | gp36 | |||||
140,235 | Australia | FN | FN | OK | OK | OK | OK | FN | FN | 89.10 | R | 640 | R | Positive | 16.80 | R | 33,68 | R | 0.70 | NR | 1+ | 1+ | – | ± | – | – | – | HIV-1 positive |
140,058 | Africa | FR | FR | OK | OK | FR | FR | OK | OK | 302.00 | R | 2560 | R | Positive | 0.26 | NR | 0,85 | NR | 0.41 | NR | NT | Negative | ||||||
140,115 | Africa | FR | OK | FR | FR | OK | OK | OK | OK | 57.30 | R | 320 | R | Positive | 0.29 | NR | 0,31 | NR | 0.51 | NR | NT | Negative | ||||||
140,134 | Africa | FR | OK | FR | OK | OK | OK | OK | OK | 46.80 | R | 1280 | R | Positive | 0.31 | NR | 0,35 | NR | 0.47 | NR | NT | Negative |
FR false reactive, FN false non-reactive, OK result is concordant with the reference result, S/CO sample signal/cut-off, OD/CO optical density/cut-off, R reactive, NR non-reactive, NT not tested